Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

A molecular probe that may one day light up tumors while surgery is in progress

Researchers at the Stanford University School of Medicine have developed a molecular probe that sets aglow tumor cells within living animals. Their goal is to use the probe to improve the diagnosis and treatment of cancer and other diseases.

10 Sep 2007

Health benefits of fruit juice

In years past, family physician Pamela Rockwell told parents not to let their children drink too much fruit juice because of its link to obesity.

5 Sep 2007

Low level of neuronal receptor LR11 linked to Alzheimer's disease

Results of a new study indicate a strong link between the loss of the neuronal receptor LR11and onset of mild cognitive impairment (MCI), often a harbinger of Alzheimer's disease.

5 Sep 2007

Halting rabies in the brain

While rabies, an ancient scourge that still kills 70,000 every year in developing countries worldwide can be combated with a series of vaccines today, it nearly is always fatal when it reaches the brain.

5 Sep 2007

3D fruit fly images to benefit brain research

The fragile head and brain of a fly are not easy things to examine but MRC scientists have figured out how to make it a little simpler. And they hope their research will shed light on human disease.

5 Sep 2007

Smoking ups Alzheimer's risk by 50%

According to a new Dutch study people over the age of 55 who are smokers put themselves at a far greater risk of developing dementia than people who do not smoke.

5 Sep 2007

Smoking and Alzheimer's disease

People who smoke are more likely to develop Alzheimer's disease or dementia than nonsmokers or those who smoked in the past, according to a study published in the September 4, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.

4 Sep 2007

Ranbaxy receives tentative approval for Galantamine tablets

Ranbaxy Laboratories Limited (RLL), has announced that the Company has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Galantamine Hydrobromide Tablets, 4mg (base), 8mg (base), and 12mg (base).

30 Aug 2007

Early surgical removal of the ovaries increases a woman's risk of neurological disorders

New research suggests that premenopausal women who have their ovaries removed have an increased risk of developing neurological disorders such as dementia and Parkinsonism.

30 Aug 2007

New form of estrogen shows potential as multiple sclerosis drug

UCLA scientists have found the first evidence that a specific form of estrogen can protect the brain from degeneration yet not increase the risk for estrogen-induced cancers of the breast and uterus.

28 Aug 2007

Zinc and macular degeneration link

A team of scientists, including three researchers at George Mason University, found that the mineral zinc could play a role in the development of macular degeneration.

28 Aug 2007

High stress and genetic risk factor lead to increased memory decline

High stress levels may contribute to memory loss among people at risk for developing Alzheimer's disease.

28 Aug 2007

Cholesterol-lowering statins may also reduce the risk of Alzheimer's

Researchers in the United States say they believe cholesterol-lowering drugs may reduce the risk of Alzheimer's.

28 Aug 2007

Binding up iron in the brain to combat Parkinson's and Alzheimer's

Duke University chemists are developing ways to bind up iron in the brain to combat the neurological devastation of Parkinson's and Alzheimer's diseases.

24 Aug 2007

Reported failure of vitamin E to prevent heart attacks may be due to underdosing

The findings, published early online in Free Radical Biology and Medicine, suggest that these earlier studies all had a fundamental flaw the doses used werent high enough to have a significant antioxidant effect.

24 Aug 2007

Potential new therapy for treatment of neurodegenerative diseases

Researchers have provided new information about how communication among neurons may be prevented from deteriorating in conditions such as Alzheimer's disease (AD).

24 Aug 2007

Discovery of new gene family essential for embryonic development

The family controls the expression of genes crucial for stem cell maintenance and differentiation, and the results may contribute sig-nificantly to the understanding of the development of cancer.

24 Aug 2007

Scientists investigate initial molecular mechanism that triggers neuronal firing

Carnegie Mellon University chemists have solved a decade-long molecular mystery that could eventually help scientists develop drug therapies to treat a variety of disorders, including epilepsy and Alzheimer's disease.

24 Aug 2007

Vaccine suppresses aggregates of tau protein - implications for Alzheimer's

A new study by NYU Medical Center researchers shows for the first time that the immune system can combat the pathological form of tau protein, a key protein implicated in Alzheimer's disease.

22 Aug 2007

Clemson scientists improve longevity of fluorescent nanoparticles

Clemson University chemists have developed a method to dramatically improve the longevity of fluorescent nanoparticles that may someday help researchers track the motion of a single molecule as it travels through a living cell.

22 Aug 2007